citric acid, anhydrous has been researched along with MODS in 5 studies
Citric Acid: A key intermediate in metabolism. It is an acid compound found in citrus fruits. The salts of citric acid (citrates) can be used as anticoagulants due to their calcium chelating ability.
citric acid : A tricarboxylic acid that is propane-1,2,3-tricarboxylic acid bearing a hydroxy substituent at position 2. It is an important metabolite in the pathway of all aerobic organisms.
Excerpt | Relevance | Reference |
---|---|---|
"During critical illness, regional anticoagulation with citrate for CRRT seems superior to heparin anticoagulation concerning tolerance and safety, mainly due to less bleeding." | 2.46 | Citrate anticoagulation for continuous renal replacement therapy in the critically ill. ( Oudemans-van Straaten, HM, 2010) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 4 (80.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Tuerdi, B | 1 |
Zuo, L | 1 |
Sun, H | 1 |
Wang, K | 1 |
Wang, Z | 1 |
Li, G | 1 |
Fearnley, RA | 1 |
Gatward, JJ | 1 |
Gattas, DJ | 1 |
Humes, HD | 1 |
Sobota, JT | 1 |
Ding, F | 1 |
Song, JH | 1 |
Oudemans-van Straaten, HM | 1 |
Bunchman, TE | 1 |
Maxvold, NJ | 1 |
Brophy, PD | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Citrate Versus Heparin in Continuous Renal Replacement Therapy : Effect on Cardiovascular System and Clot Circuit in Critically Ill Patients[NCT04865510] | 41 participants (Actual) | Interventional | 2019-02-04 | Completed | |||
Novel Extracorporeal Treatment to Modulate Hyperinflammation in COVID-19 Patients[NCT04353674] | 40 participants (Anticipated) | Interventional | 2020-04-28 | Recruiting | |||
Simplified Regional Citrate Anticoagulation Protocols for CVVH, CVVHDF and SLED Focused on the Prevention of RRT-related Hypophosphatemia and Optimization of Acid-base Balance: a Pilot Study[NCT03976440] | 30 participants (Anticipated) | Observational | 2019-06-01 | Active, not recruiting | |||
Evaluation of a Simplified Protocol for Regional Citrate Anticoagulation in Continuous Venovenous Hemodiafiltration[NCT00583765] | 20 participants (Actual) | Observational | 2005-04-30 | Completed | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
1 review available for citric acid, anhydrous and MODS
Article | Year |
---|---|
Citrate anticoagulation for continuous renal replacement therapy in the critically ill.
Topics: Acid-Base Imbalance; Aged; Anticoagulants; Buffers; Citric Acid; Citric Acid Cycle; Clinical Protoco | 2010 |
1 trial available for citric acid, anhydrous and MODS
Article | Year |
---|---|
A selective cytopheretic inhibitory device to treat the immunological dysregulation of acute and chronic renal failure.
Topics: Acute Kidney Injury; Anticoagulants; Antigen-Presenting Cells; Atherosclerosis; Cardiovascular Disea | 2010 |
3 other studies available for citric acid, anhydrous and MODS
Article | Year |
---|---|
Safety and efficacy of regional citrate anticoagulation in continuous blood purification treatment of patients with multiple organ dysfunction syndrome.
Topics: Adult; Aged; Anticoagulants; Blood Coagulation; Blood Pressure; Citrates; Citric Acid; Female; Gluco | 2017 |
Iatrogenic hypercalcaemia including Takotsubo cardiomyopathy in regional citrate anticoagulation for continuous venovenous haemodialysis.
Topics: Anticoagulants; Citric Acid; Electrocardiography; Female; Fluid Therapy; Hemofiltration; Heparin; Hu | 2014 |
Pediatric convective hemofiltration: Normocarb replacement fluid and citrate anticoagulation.
Topics: Adolescent; Anticoagulants; Bicarbonates; Child; Child, Preschool; Citric Acid; Clinical Protocols; | 2003 |